CC BY-NC-ND 4.0 · Laryngorhinootologie 2021; 100(S 02): S120-S121
DOI: 10.1055/s-0041-1727957
Abstracts
Head-Neck-Oncology: Molecular Tumorboard

Characterisation of the molecular landscape of precancerous lesions in the upper aerodigestive tract

A Lechner
1   Klinikum der Universität München, Klinik und Poliklinik für Hals-Nasen-Ohrenheilkunde, München
,
C Walz
2   Klinikum der Universität München, Institut für Pathologie, München
,
C Reichel
1   Klinikum der Universität München, Klinik und Poliklinik für Hals-Nasen-Ohrenheilkunde, München
,
P Baumeister
1   Klinikum der Universität München, Klinik und Poliklinik für Hals-Nasen-Ohrenheilkunde, München
,
Jörg Kumbrink
2   Klinikum der Universität München, Institut für Pathologie, München
,
A Jung
2   Klinikum der Universität München, Institut für Pathologie, München
,
O Gires
1   Klinikum der Universität München, Klinik und Poliklinik für Hals-Nasen-Ohrenheilkunde, München
,
M Canis
1   Klinikum der Universität München, Klinik und Poliklinik für Hals-Nasen-Ohrenheilkunde, München
,
S Flach
1   Klinikum der Universität München, Klinik und Poliklinik für Hals-Nasen-Ohrenheilkunde, München
› Author Affiliations
 
 

    The clinical significance of a dysplastic lesion in the upper aerodigestive tract lies in its potential to transform into an invasive head and neck squamous cell carcinoma (HNSCC). However, due to varying criteria and lack of unifying classification systems it is difficult to histopathologically distinguish between the different stages of disease. Hence there is a need for early detection biomarkers and novel therapeutic strategies to treat HNSCC in its early or even precancerous stages, thus improving the outcome of this patient cohort.

    We have conducted targeted next generation sequencing (NGS) on serially collected paired non-dysplastic, dysplastic and invasive FFPE tissue samples from 2 patients. Over the course of the disease (4 years and 15 years), serial biopsies were taken from various precancerous and cancerous lesions in those patients. Using targeted gene panel sequencing, the clonal evolution and timely progression from precancerous to invasive stages of disease were investigated. Sequencing of at least 6 tissue samples per case demonstrated different somatic variants, allowing us to explore the temporal relationship between non-dysplastic, dysplastic and invasive lesions in the upper aerodigestive tract. We demonstrated that the mutational profile of FFPE biopsies from precancerous and cancerous tissue samples by targeted NGS-based assays can be used to investigate the clonal evolution of HNSCC.

    Poster-PDF A-1441.pdf


    #

    Conflict of interest

    Der Erstautor gibt keinen Interessenskonflikt an.

    Address for correspondence

    Dr. med. Lechner Axel
    Klinikum der Universität München, Klinik und Poliklinik für Hals-Nasen-Ohrenheilkunde
    Marchioninistraße 15
    81377 München

    Publication History

    Article published online:
    13 May 2021

    © 2021. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

    Georg Thieme Verlag KG
    Rüdigerstraße 14, 70469 Stuttgart, Germany